Integrated 5-hydroxymethylcytosine and fragmentation signatures as enhanced biomarkers in lung cancer

BACKGROUND: Lung cancer is one of most common cancers worldwide, with a 5-year survival rate of less than 20%, which is mainly due to late-stage diagnosis. Noninvasive methods using 5-hydroxymethylation of cytosine (5hmC) modifications and fragmentation profiles from 5hmC cell-free DNA (cfDNA) seque...

Descripción completa

Detalles Bibliográficos
Autores principales: Hu, Xinlei, Luo, Kai, Shi, Hui, Yan, Xiaoqin, Huang, Ruichen, Zhao, Bi, Zhang, Jun, Xie, Dan, Zhang, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787948/
https://www.ncbi.nlm.nih.gov/pubmed/35073982
http://dx.doi.org/10.1186/s13148-022-01233-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787948/
https://www.ncbi.nlm.nih.gov/pubmed/35073982
http://dx.doi.org/10.1186/s13148-022-01233-7

Ejemplares similares